12 completed, 2 suspended, 2 unknown, 1 terminated. 10 Phase 2, 4 Not applicable, 1 Phase 1, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 10 | Completed 8, Suspended 2 |
| Not applicable | 4 | Completed 3, Terminated 1 |
| Phase 1 | 1 | Completed 1 |
| Phase 3 | 1 | Unknown 1 |
| Phase 4 | 1 | Unknown 1 |
Follow Agouron Pharmaceuticals: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nelfinavir and M8 Drug-level Monitoring in HIV-1 Infection Nelfinavir - HIV Infections | Not applicable | Completed | University of Wisconsin, Madison | 20 | 2003-08-01 | 2019-03-22 |
| Effectiveness of Adding Interleukin-2 to Anti-HIV Drugs in Patients Recently Infected With HIV Lamivudine/Zidovudine, Nelfinavir mesylate, Aldesleukin - HIV Infections | Not applicable | Completed | National Institute of Allergy and Infectious Diseases (NIAID) | 398 | 2003-02-01 | 2015-03-09 |
| Safety and Effectiveness of 3 Anti-HIV Treatments in Patients Who Have Failed Previous Treatments Containing Nelfinavir Indinavir sulfate, Ritonavir, Delavirdine mesylate - HIV Infections | Not applicable | Terminated | Agouron Pharmaceuticals | 60 | 2000-08-01 | 2005-06-24 |
| A Study of Capravirine Plus VIRACEPT Plus Two Nucleoside Reverse Transcriptase Inhibitors in HIV-Infected Patients Who Failed Previous Anti-HIV Treatments Capravirine, Nelfinavir mesylate - HIV Infections | Phase 2 | Completed | Agouron Pharmaceuticals | 350 | 2000-02-01 | 2005-06-24 |
| Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy Capravirine, Nelfinavir mesylate - HIV Infections | Phase 2 | Completed | Agouron Pharmaceuticals | 75 | 2000-01-01 | 2005-06-24 |
| Treatment With Nelfinavir or Efavirenz of HIV-Infected Patients Who Have Never Received Anti-HIV Drugs Nelfinavir mesylate, Efavirenz, Lamivudine - HIV Infections | Phase 4 | Unknown | Agouron Pharmaceuticals | 200 | 1999-12-01 | 2005-06-24 |
| Safety and Effectiveness of a New Anti-HIV Drug (AG1549) in Combination With Other Anti-HIV Drugs in HIV-Infected Patients Lamivudine/Zidovudine, Capravirine, Nelfinavir mesylate - HIV Infections | Phase 2 | Suspended | Agouron Pharmaceuticals | 30 | 1999-11-01 | 2005-06-24 |
| Effectiveness of a New Anti-HIV Drug (AG1549) Plus Viracept (Nelfinavir) Plus Combivir (Zidovudine/Lamivudine) in HIV-Infected Patients Lamivudine/Zidovudine, Capravirine, Nelfinavir mesylate - HIV Infections | Phase 2 | Suspended | Agouron Pharmaceuticals | 350 | 1999-08-01 | 2005-06-24 |
| A Study of Viracept in AIDS Patients With Mycobacterium Avium Complex Disease (MAC) Nelfinavir mesylate - Mycobacterium Avium-Intracellulare Infection, HIV Infections | Phase 2 | Completed | Agouron Pharmaceuticals | 2005-06-24 | ||
| Phase I Study of Safety, Tolerability, and Pharmacokinetics of Viracept in HIV-1 Infected Children and Exposed Infants Nelfinavir mesylate - HIV Infections | Phase 1 | Completed | Agouron Pharmaceuticals | 24 | 2005-06-24 | |
| Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune) Lamivudine/Zidovudine, HIV-1 Immunogen, Nelfinavir mesylate - HIV Infections | Phase 3 | Unknown | Agouron Pharmaceuticals | 688 | 2005-06-24 | |
| Viracept Expanded Access Program Nelfinavir mesylate - HIV Infections | Not applicable | Completed | Agouron Pharmaceuticals | 2005-06-24 | ||
| A Study of Viracept in HIV-Positive Women Nelfinavir mesylate - HIV Infections | Phase 2 | Completed | Agouron Pharmaceuticals | 2005-06-24 | ||
| A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3 Nelfinavir mesylate - Sarcoma, Kaposi, HIV Infections | Phase 2 | Completed | Agouron Pharmaceuticals | 20 | 2005-06-24 | |
| Safety and Effectiveness of Treating HIV-Positive Patients With an HIV Vaccine (Remune) HIV-1 Immunogen - HIV Infections | Phase 2 | Completed | Agouron Pharmaceuticals | 40 | 2005-06-24 | |
| A Study of Viracept in AIDS Patients With Cytomegalovirus Retinitis Nelfinavir mesylate - Cytomegalovirus Retinitis, HIV Infections | Phase 2 | Completed | Agouron Pharmaceuticals | 2005-06-24 | ||
| A Study on the Safety and Effectiveness of Twice-Daily Nelfinavir Plus Twice-Daily Indinavir Plus Efavirenz in HIV-Positive Patients Who Have Never Taken Non-Nucleoside Reverse Transcriptase Inhibitors (NNRTIs) or Protease Inhibitors Indinavir sulfate, Nelfinavir mesylate, Efavirenz - HIV Infections | Phase 2 | Completed | Merck Sharp & Dohme LLC | 6 | 2005-06-24 |
HIV Infections (17) · AIDS-Related Opportunistic Infections (3) · Acquired Immunodeficiency Syndrome (2) · Cytomegalovirus Retinitis (1) · Disease Progression (1) · Mycobacterium avium-intracellulare Infection (1) · Sarcoma, Kaposi (1) · Skin Neoplasms (1)
Nelfinavir (15) · capravirine (4) · lamivudine, zidovudine drug combination (4) · HIV-1 immunogen, incomplete Freund's adjuvant (2) · Indinavir (2) · efavirenz (2) · Delavirdine (1) · Didanosine (1) · Interleukin-2 (1) · Lamivudine (1) · Ritonavir (1) · Stavudine (1) · Zidovudine (1) · aldesleukin (1) · keyhole-limpet hemocyanin (1)
United States (17) · Dominican Republic (2) · Puerto Rico (2) · Canada (1)
Andrew Urban, MD (1) · Jay Levy (1)